BioMed Research International

Cancer Diagnostic and Predictive Biomarkers


Publishing date
17 Jan 2014
Status
Published
Submission deadline
30 Aug 2013

1Department of Experimental Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy

2Department of Microbiology and Immunology, Institute of Human Virology, Baltimore, MD, USA

3Department of Research, International Prevention Research Institute, Lyon, France

4Department of Pathology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy

5Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA


Cancer Diagnostic and Predictive Biomarkers

Description

The Omics revolution along with the Next Generation Sequencing has recently opened the possibility to identify molecular changes and metabolic pathways specific for each cancer with the resulting possibility of further molecular subclassification of each cancer histotype and identification of a more reliable prognosis and appropriate treatment. A further result is the reduction of overtreatment of those with higher responsivity and better prognosis. Furthermore, such studies do have the possibility of identifying specific cancer targets, with higher effectiveness of chemotherapy and much lower general toxicity. The whole field is in a current turmoil, and a specific issue focused on the clinical validation of newly identified biomarkers, able to bridge molecular mechanisms with clinical diagnosis and therapeutic responsivity, should be very successful and attract the entire scientific community. Potential topics include, but are not limited to:

  • Biomarkers in pathogen-related cancers
  • Biomarkers of cancer progression
  • Inflammation-related biomarkers in cancer diagnosis and progression
  • miRNA as a biomarker of cancer progression and therapeutic targets
  • Epigenetic biomarkers in cancer immunology
  • Tissue cancer biomarkers for targeted therapy
  • Plasma/serum markers for clinical diagnosis and followup

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/bmri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/bmri/oncology/cdpb/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 980163
  • - Editorial

Cancer Diagnostic and Predictive Biomarkers

Franco M. Buonaguro | David Pauza | ... | Francesco M. Marincola
  • Special Issue
  • - Volume 2014
  • - Article ID 801640
  • - Research Article

BMP-4 Genetic Variants and Protein Expression Are Associated with Platinum-Based Chemotherapy Response and Prognosis in NSCLC

Sun Xian | Lang Jilu | ... | Fu Songbin
  • Special Issue
  • - Volume 2014
  • - Article ID 710642
  • - Research Article

Impact of Immunogenetic IL28B Polymorphism on Natural Outcome of HCV Infection

Valli De Re | Laura Gragnani | ... | Anna Linda Zignego
  • Special Issue
  • - Volume 2014
  • - Article ID 398097
  • - Research Article

ELFN1-AS1: A Novel Primate Gene with Possible MicroRNA Function Expressed Predominantly in Human Tumors

Dmitrii E. Polev | Iuliia K. Karnaukhova | ... | Andrei P. Kozlov
  • Special Issue
  • - Volume 2014
  • - Article ID 742831
  • - Review Article

Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43

Franca Maria Tuccillo | Annamaria de Laurentiis | ... | Giuseppe Scala
  • Special Issue
  • - Volume 2014
  • - Article ID 361020
  • - Review Article

CDK/CCN and CDKI Alterations for Cancer Prognosis and Therapeutic Predictivity

Patrizia Bonelli | Franca Maria Tuccillo | ... | Franco Maria Buonaguro
  • Special Issue
  • - Volume 2014
  • - Article ID 234813
  • - Clinical Study

The Preoperative Maximum Standardized Uptake Value Measured by 18F-FDG PET/CT as an Independent Prognostic Factor of Overall Survival in Endometrial Cancer Patients

Malgorzata Walentowicz-Sadlecka | Bogdan Malkowski | ... | Marek Grabiec
  • Special Issue
  • - Volume 2014
  • - Article ID 735659
  • - Research Article

Isocitrate Dehydrogenase-1 Mutations as Prognostic Biomarker in Glioblastoma Multiforme Patients in West Bohemia

J. Polivka | J. Polivka | ... | O. Topolcan
  • Special Issue
  • - Volume 2014
  • - Article ID 948264
  • - Research Article

Beta-Catenin and Epithelial Tumors: A Study Based on 374 Oropharyngeal Cancers

Angela Santoro | Giuseppe Pannone | ... | Lorenzo Lo Muzio
  • Special Issue
  • - Volume 2014
  • - Article ID 476789
  • - Review Article

The Functional Role of MnSOD as a Biomarker of Human Diseases and Therapeutic Potential of a New Isoform of a Human Recombinant MnSOD

Antonella Borrelli | Antonietta Schiattarella | ... | Aldo Mancini
BioMed Research International
 Journal metrics
Acceptance rate30%
Submission to final decision67 days
Acceptance to publication32 days
CiteScore3.600
Impact Factor2.276
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.